Detact Diagnostics
PrivateLast Round
Grant
May 1, 2026
Total Funding Raised
$9.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Detact Diagnostics is a biotechnology company that develops rapid, affordable infection detection solutions using its proprietary VIPER® platform technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Detact Diagnostics Comparables
Compare Detact Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microbiosensor Ltd | 81% | |
| Neomend | 72% | |
| Lumos Diagnostics Holdings Limited | 71% |
Detact Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2026 | ||||
| Grant | Oct 28, 2025 | ||||
| Grant | Nov 7, 2024 | ||||
| Grant | Oct 1, 2024 | ||||
| VC Round | Dec 17, 2020 | ||||
VC Round | Apr 19, 2017 |
Key People
Founding team and executive leadership
Detact Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bill & Melinda Gates Foundation | Grant |
| Noordelijke Ontwikkelings Maatschappij | VC Round |
| Pacific6 Enterprises | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 156% MoM.
- May 1, 2026
$466K grant from the Bill & Melinda Gates Foundation.
Detact Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Detact Diagnostics's valuation, stock price, and market status.
Is Detact Diagnostics a public or private company?
Detact Diagnostics is a private company.
What is the current stock price of Detact Diagnostics?
Detact Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Detact Diagnostics worth (valuation)?
Valuation information for Detact Diagnostics is not publicly available.
Can I buy Detact Diagnostics stock?
Detact Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Detact Diagnostics's last funding round?
Detact Diagnostics's most recent funding round was Grant on May 1, 2026.
Who are the main investors in Detact Diagnostics?
Key investors in Detact Diagnostics include Bill & Melinda Gates Foundation, Noordelijke Ontwikkelings Maatschappij, Pacific6 Enterprises.
Will Detact Diagnostics IPO soon?
No public IPO plans have been announced for Detact Diagnostics.
How can I track Detact Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Detact Diagnostics's secondary market activity and sign up for updates.